- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.09. | Atelerix and Rodon Global Partner to Enhance Biomedical Logistics | ||
| 03.09. | Aptamer Group Partners with Invizius to Develop Next-Gen Complement System Therapies | ||
| 03.09. | Parabilis Medicines Names Fawzi Benzaghou Chief Medical Officer | ||
| 03.09. | Charles River Bolsters Cell Therapy Platform with Akadeum's T Cell Isolation Technology | ||
| 03.09. | Tobin Scientific Appoints Julia Bushell as Quality & Regulatory Affairs SVP | ||
| 03.09. | Ryvu Therapeutics to Support Clinical Trials for BioNTech in Poland | ||
| 03.09. | Ori Biotech's IRO Platform Receives FDA AMT Designation | ||
| 03.09. | Experic Taps Jeffrey Shane as Chief Commercial Officer | ||
| 03.09. | Cytovance Biologics Expands Services with In-House Formulation Development | ||
| 03.09. | CPTx Appoints David Maier to Lead gxstrands Business Unit | ||
| 02.09. | Curida Launches New Unified Brand Identity | ||
| 02.09. | Grand River Aseptic Manufacturing Names New CEO | ||
| 02.09. | RareMed Solutions Expands Relationship with PTC Therapeutics | ||
| 02.09. | Arrowhead Pharmaceuticals, Novartis Ink $2.2 Billion Deal for Parkinson's Therapy and RNAi Platform | ||
| 02.09. | IL Group Delivers Tamper-Evident Labeling Solution for Prefilled Syringe Launch | ||
| 02.09. | eXmoor Pharma & Anthony Nolan Partner to Advance Cell Therapy Development | ||
| 02.09. | Quotient Sciences, CPI Form RNA Drug Development Joint Venture | ||
| 02.09. | Thermo Fisher Scientific Acquires NJ Site from Sanofi | ||
| 02.09. | Delpharm to Expand and Upgrade Boucherville Site | ||
| 02.09. | Enveric Biosciences Relocates HQ to Cambridge, MA | ||
| 02.09. | Merck KGaA, Darmstadt, Germany Names New Global Head of R&D and CMO for Healthcare Business Sector | ||
| 02.09. | Sanofi's Wayrilz Approved by FDA to Treat Immune Thrombocytopenia | ||
| 29.08. | Eurofins Viacor BioPharma Services to Relocate to New Facility in Lenexa, KS | ||
| 29.08. | Accro Bioscience Grants Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor in Greater China | ||
| 29.08. | Symbiosis Appoints Wendy Cook as New Qualified Person |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .